Elanix Biotechnologies’s Partner Transwell Biotech Starts First Clinical Study with Progenitor Cell Treatment for Skin Graft Wounds First Patient Treated in Phase I/II TWB-103 Trial

20-07-2017

Elanix Biotechnologies’s Partner Transwell Biotech Starts First Clinical Study with Progenitor Cell Treatment for Skin Graft Wounds First Patient Treated in Phase I/II TWB-103 Trial